These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14616255)

  • 1. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
    Kaleli B; Yildirim B; Demir S; Alatas E
    Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1107-11. PubMed ID: 14616255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial.
    Garnero P; Jamin C; Benhamou CL; Pelissier C; Roux C
    Hum Reprod; 2002 Oct; 17(10):2748-53. PubMed ID: 12351557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels.
    Eviö S; Tiitinen A; Turpeinen U; Ylikorkala O
    Fertil Steril; 2000 Dec; 74(6):1080-3. PubMed ID: 11119731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Am J Obstet Gynecol; 2000 Sep; 183(3):575-82. PubMed ID: 10992176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women.
    Dahm AE; Eilertsen AL; Goeman J; Olstad OK; Ovstebø R; Kierulf P; Mowinckel MC; Skretting G; Sandset PM
    Thromb Res; 2012 Jul; 130(1):45-51. PubMed ID: 22217510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy.
    Norris LA; Joyce M; O'Keeffe N; Sheppard BL; Bonnar J
    Maturitas; 2002 Oct; 43(2):125-33. PubMed ID: 12385861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hormone replacement therapy and tibolone on serum total homocysteine levels in postmenopausal women.
    Christodoulakos GE; Panoulis CP; Lambrinoudaki IV; Dendrinos SG; Rizos DA; Creatsas GC
    Eur J Obstet Gynecol Reprod Biol; 2004 Jan; 112(1):74-9. PubMed ID: 14687744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
    Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
    Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
    D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
    Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen.
    Nathorst-Böös J; Hammar M
    Maturitas; 1997 Jan; 26(1):15-20. PubMed ID: 9032742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
    Nijland EA; Weijmar Schultz WC; Nathorst-Boös J; Helmond FA; Van Lunsen RH; Palacios S; Norman RJ; Mulder RJ; Davis SR;
    J Sex Med; 2008 Mar; 5(3):646-56. PubMed ID: 18304284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.
    Kotecha PT; Godsland IF; Crook D; Stevenson JC
    Clin Endocrinol (Oxf); 2020 Apr; 92(4):303-311. PubMed ID: 31925799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation.
    Eilertsen AL; Qvigstad E; Andersen TO; Sandvik L; Sandset PM
    Maturitas; 2006 Oct; 55(3):278-87. PubMed ID: 16713143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous combined hormone replacement therapy with oral 17beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women.
    Ventura P; Cagnacci A; Malmusi S; Panini R; Baldassari F; Arangino S; Volpe A; Salvioli G
    Menopause; 2001; 8(4):252-8. PubMed ID: 11449082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    Hammar ML; van de Weijer P; Franke HR; Pornel B; von Mauw EM; Nijland EA;
    BJOG; 2007 Dec; 114(12):1522-9. PubMed ID: 17995496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women.
    Brynhildsen J; Hammar M
    Menopause; 2002; 9(2):137-44. PubMed ID: 11875333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Menopause; 1999; 6(4):299-306. PubMed ID: 10614676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.